Review
doi: 10.2967/jnumed.115.157446.
Epub 2015 May 7.
⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments
Affiliations
- PMID: 25952741
- DOI: 10.2967/jnumed.115.157446
Item in Clipboard
Review
⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments
J Nucl Med.
2015 Jul.
Free article
Abstract
Radioembolization is an established treatment modality that has been subjected to many improvements over the last decade. Developments are occurring at a high pace, affecting patient selection and treatment. The aim of this review is therefore to provide an overview of current practice, with a focus on recent developments in the field of radioembolization. Several practical issues and recommendations in the application of radioembolization will be discussed, ranging from patient selection to treatment response and future applications.
Keywords: 90Y; dosimetry; hepatic vasculature; liver malignancies; radioembolization.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Similar articles
-
Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques.J Nucl Med. 2018 Nov;59(11):1649-1654. doi: 10.2967/jnumed.116.186346. Epub 2018 Aug 2. J Nucl Med. 2018. PMID: 30072501 Review.
-
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):559-75. doi: 10.1007/s00259-015-3157-8. Epub 2015 Sep 4. Eur J Nucl Med Mol Imaging. 2016. PMID: 26338177 Free PMC article. Review.
-
Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.J Nucl Med. 2015 Aug;56(8):1157-62. doi: 10.2967/jnumed.114.153346. Epub 2015 Jun 18. J Nucl Med. 2015. PMID: 26089551
-
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007. J Vasc Interv Radiol. 2014. PMID: 24461133
-
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.J Nucl Med. 2012 Feb;53(2):255-63. doi: 10.2967/jnumed.111.094235. J Nucl Med. 2012. PMID: 22302962
Cited by
-
Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips.Semin Intervent Radiol. 2024 Mar 14;41(1):63-78. doi: 10.1055/s-0044-1779715. eCollection 2024 Feb. Semin Intervent Radiol. 2024. PMID: 38495257 Review. No abstract available.
-
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment.J Gastrointest Oncol. 2024 Feb 29;15(1):356-367. doi: 10.21037/jgo-23-890. Epub 2024 Feb 26. J Gastrointest Oncol. 2024. PMID: 38482235 Free PMC article.
-
PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study.PLoS One. 2024 Feb 29;19(2):e0271711. doi: 10.1371/journal.pone.0271711. eCollection 2024. PLoS One. 2024. PMID: 38421965 Free PMC article.
-
Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer.J Interv Med. 2023 Sep 19;6(4):153-159. doi: 10.1016/j.jimed.2023.09.001. eCollection 2023 Nov. J Interv Med. 2023. PMID: 38312126 Free PMC article.
-
A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy.J Nanobiotechnology. 2024 Jan 3;22(1):7. doi: 10.1186/s12951-023-02268-5. J Nanobiotechnology. 2024. PMID: 38166931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
